SHMT2 and colorectal carcinoma: Colorectal cancer (CRC) reveals complex adaptation to changing environments, with serine hydroxymethyltransferase 2-mediated mitochondrial serine metabolism contributing to 5-Fluorouracil (5-FU) resistance (Pranzini et al., 2022).